37 related articles for article (PubMed ID: 26940529)
1. How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.
Patel MI; Schupp CW; Gomez SL; Chang ET; Wakelee HA
J Clin Oncol; 2013 Oct; 31(28):3572-8. PubMed ID: 23960183
[TBL] [Abstract][Full Text] [Related]
2. The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials.
Siddiqui F; Bae K; Langer CJ; Coyne JC; Gamerman V; Komaki R; Choy H; Curran WJ; Watkins-Bruner D; Movsas B
J Thorac Oncol; 2010 May; 5(5):631-9. PubMed ID: 20432520
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic criteria for cancer cachexia: data versus dogma.
Martin L
Curr Opin Clin Nutr Metab Care; 2016 May; 19(3):188-98. PubMed ID: 26945342
[TBL] [Abstract][Full Text] [Related]
4. Combined Therapy of Low-Dose Angiotensin Receptor-Neprilysin Inhibitor and Sodium-Glucose Cotransporter-2 Inhibitor Prevents Doxorubicin-Induced Cardiac Dysfunction in Rodent Model with Minimal Adverse Effects.
Kim D; Jang G; Hwang J; Wei X; Kim H; Son J; Rhee SJ; Yun KH; Oh SK; Oh CM; Park R
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559124
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Weight Loss during Chemoradiotherapy for Unresectable Esophageal Cancer: Real-World Results.
Huang TT; Chou SY; Lin YH; Li SH; Chen YH; Lu HI; Lo CM; Fang FM; Chiu YC; Chou YP; Wang YM
Life (Basel); 2022 May; 12(5):. PubMed ID: 35629373
[TBL] [Abstract][Full Text] [Related]
6. Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.
Fujii H; Araki A; Iihara H; Kaito D; Hirose C; Kinomura M; Yamazaki M; Endo J; Inui T; Yanase K; Sasaki Y; Gomyo T; Sakai C; Kawae D; Kitamura Y; Fukui M; Kobayashi R; Ohno Y; Suzuki A
Mol Clin Oncol; 2022 Apr; 16(4):91. PubMed ID: 35251642
[TBL] [Abstract][Full Text] [Related]
7. Nutritional Interventions in Cancer Cachexia: Evidence and Perspectives From Experimental Models.
van de Worp WRPH; Schols AMWJ; Theys J; van Helvoort A; Langen RCJ
Front Nutr; 2020; 7():601329. PubMed ID: 33415123
[TBL] [Abstract][Full Text] [Related]
8. Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Willemsen ACH; Degens JHRJ; Baijens LWJ; Dingemans AC; Hoeben A; Hoebers FJP; De Ruysscher DKM; Schols AMWJ
Front Nutr; 2020; 7():600612. PubMed ID: 33324671
[No Abstract] [Full Text] [Related]
9. Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer.
Storey CL; Hanna GG; Greystoke A;
Br J Cancer; 2020 Dec; 123(Suppl 1):28-35. PubMed ID: 33293673
[TBL] [Abstract][Full Text] [Related]
10. The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer.
Jain R; Coss C; Whooley P; Phelps M; Owen DH
Curr Oncol Rep; 2020 May; 22(6):54. PubMed ID: 32409907
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Relationship of Radiation Dose Exposed to the Length of Esophagus and Weight Loss in Patients with Lung Cancer.
Han P; Hales R; Lakshminarayanan P; Cheng Z; Elledge C; Negron A; Hazell S; Hu C; Friedes C; Anderson L; Hoff J; Marrone K; Quon H; McNutt T; Voong KR
Pract Radiat Oncol; 2020; 10(4):255-264. PubMed ID: 32201321
[TBL] [Abstract][Full Text] [Related]
12. Combined Chemoradiotherapy-induced Weight Loss Decreases Survival in Locally Advanced Non-small Cell Lung Cancer Patients.
Kim YJ; Song C; Eom KY; Kim IA; Kim JS
In Vivo; 2019; 33(3):955-961. PubMed ID: 31028222
[TBL] [Abstract][Full Text] [Related]
13. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival.
Kiss N; Beraldo J; Everitt S
Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673
[TBL] [Abstract][Full Text] [Related]
14. Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI.
Lin L; Zhao J; Hu J; Huang F; Han J; He Y; Cao X
J Cancer; 2018; 9(3):528-534. PubMed ID: 29483958
[No Abstract] [Full Text] [Related]
15. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
Vagnildhaug OM; Blum D; Wilcock A; Fayers P; Strasser F; Baracos VE; Hjermstad MJ; Kaasa S; Laird B; Solheim TS;
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):789-797. PubMed ID: 28627024
[TBL] [Abstract][Full Text] [Related]
16. A critical review of recent developments in radiotherapy for non-small cell lung cancer.
Baker S; Dahele M; Lagerwaard FJ; Senan S
Radiat Oncol; 2016 Sep; 11(1):115. PubMed ID: 27600665
[TBL] [Abstract][Full Text] [Related]
17. An analysis of the relationship between metastases and cachexia in lung cancer patients.
Shiono M; Huang K; Downey RJ; Consul N; Villanueva N; Beck K; Fenn K; Dietz D; Yamaguchi T; Kato S; Divgi C; Kalinsky K; Wei Y; Zhang Y; Borczuk AC; Inoue A; Halmos B; Acharyya S
Cancer Med; 2016 Sep; 5(9):2641-8. PubMed ID: 27485414
[TBL] [Abstract][Full Text] [Related]
18. Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC.
Sanders KJ; Hendriks LE; Troost EG; Bootsma GP; Houben RM; Schols AM; Dingemans AM
J Thorac Oncol; 2016 Jun; 11(6):873-9. PubMed ID: 26940529
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
